Table 4. Funding of the included studies.
| Sample 1 (N = 144) 11 | Sample 2 (N = 115) 11 | |
|---|---|---|
| n (%) | n (%) | |
| Funding status | ||
| Not funded | 38 (26) | 9 (8) |
| Funded | 97 (67) | 103 (90) |
| Not reported | 9 (7) | 3 (2) |
| Reported Source(s) of Funding | N = 97 * | N = 103 * |
| Internally funded | 40 (41) | 47 (46) |
| Governmental | 59 (61) | 47 (46) |
| Private for Profit | 11 (11) | 16 (16) |
| Private not for Profit | 19 (20) | 22 (21) |
| Intergovernmental | 12 (12) | 8 (8) |
| Academic | 14 (14) | 8 (8) |
| Statement of the funder’s role | 55/97 (57) | 61/103 (59) |
*Total does not add up to 100 due to overlap
11 sample 1 includes articles of any type of original research. Sample 2 is restricted to only randomized controlled trials (RCTs)